Is BUD a Buy or a Sell? The Bull and Bear Case (2026)

That depends on which case you find more convincing, and both are on this page. The bull case rests on Premiumization and pricing power, with recent revenue at Q1 2026 revenue of roughly $15.3 billion, up about 12% year over year on price and mix rather than large volume gains. The bear case rests on the clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock. Analysts covering it are spread from $84.50 to $111.00, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. The clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $84.50, +0.7% from the $83.95 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

Premiumization and pricing power. AB InBev's growth engine is mix and price rather than raw volume: selling more premium and super-premium beers like Corona and Michelob Ultra, plus disciplined price increases, lifts revenue faster than the number of drinks sold. The most optimistic analyst target on BUD is $111.00, +32.2% from the $83.95 price. That figure is only reachable if this thesis works close to its best case.

The clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock. As an ADR of a Belgium-based company that earns across many currencies, BUD carries currency risk, and a strong US dollar can reduce reported results and the value of foreign earnings for US holders. Volume growth is structurally slow in developed markets, and beer faces long-run competition from wine, spirits, cannabis, and a broader moderation-in-drinking trend among younger consumers. In the United States, the company is still recovering from the 2023 Bud Light boycott, which dented its mainstream domestic share. Emerging-market exposure adds economic and political volatility, and input-cost and tariff swings can pressure margins. Because so much of the thesis rests on deleveraging, any setback to free cash flow directly threatens the core investment case. The most pessimistic published target is $84.50, +0.7% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

Anheuser-Busch InBev SA/NV is the largest beer company in the world, formed through a series of mega-mergers that combined Anheuser-Busch, InBev, and SABMiller.

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Premiumization and pricing power) stalling in the reported numbers rather than in the narrative, the risk above (the clearest risk is the debt load itself: while falling, it remains large, and slow deleveraging or higher interest rates would keep pressure on the stock) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

That depends on your goals, time horizon, and risk tolerance, and this is not investment advice. The bull case is the world's largest brewer with iconic brands, strong emerging-market reach, record recent earnings, and a deleveraging path that could re-rate the stock. The bear case is a still-large debt load, currency risk from its ADR structure, slow developed-market volumes, and lingering US Bud Light weakness. Weigh both against your portfolio.

AB InBev is the largest beer company in the world. It brews and sells global brands like Budweiser, Corona, and Stella Artois, plus Michelob Ultra and many local champion brands across Latin America, Africa, and Asia, along with a growing Beyond Beer range. Its results are driven by premiumization, pricing, and emerging-market volumes rather than fast overall growth.

BUD trades as an American Depositary Receipt, which is a US-listed security representing shares of Anheuser-Busch InBev, a company based in Belgium. You buy and sell it in dollars through a normal US broker like any stock, but the underlying earnings and any dividend are generated in foreign currencies, so a strong or weak US dollar can affect your returns independent of the business itself.